Skip to Content
Search Menu

Vedolizumab and Ustekinumab as Treatment for Patients with Ulcerative Colitis

In this MEDtalk, Thea Wiken elaborates on her study presented at ECCO 2024, comparing the effect of vedolizumab and ustekinumab in patients with ulcerative colitis who previously have been treated with anti-TNF-alpha inhibitors. The results show increased clinical remission in both groups, but only increased biochemical remission in patients treated with ustekinumab. The study also suggests that therapeutic drug management can have potential benefits in the treatment of ulcerative colitis patients.
Thea Wiken

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Relateret indhold

Jonas Julius Rudbæk

Unidentified Trigger can Prompt Pathological Changes Many Years Prior to Clinical Onset of Crohn’s Disease and Colitis Ulcerosa

/ Jonas Julius Rudbæk
CrohnsIBDUlcerative colitis Play the Video 13:37
Abhinav Vasudevan

Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease

/ Abhinav Vasudevan
CrohnsIBDUlcerative colitis Play the Video 06:43
Maiara Brusco De Freitas

Impaired Growth and Nutritional Status Can Be Observed Several Years Before Diagnosis of Childhood-Onset IBD

/ Maiara Brusco De Freitas
CrohnsIBDUlcerative colitis Play the Video 6:10

Increased Incidence of Comorbid Diseases 10 Years Prior to IBD Diagnosis

/ Anthony C. Ebert
ECCO24IBD Play the Video 6:47
Gorm Roager Madsen

Periodontitis Seems to Be Linked to Increased IBD Disease Activity and Disability

/ Gorm Roager Madsen
ECCO24IBD Play the Video 4:05
Marc Ferrante

Mirikizumab As a Potential New Treatment in Patients with Crohn’s Disease

/ Marc Ferrante
CrohnsECCO24 Play the Video 8:36
Daniele Noviello

Risankizumab Downregulates IL-23-Induced Mucosal Pathogenic Th17 Cells in Patients with Crohn’s Disease

/ Daniele Noviello
CrohnsECCO24 Play the Video 5:49
Anja Poulsen

Colon Involvement or Isolated Small Intestinal Resection is Associated with a Higher Risk of Re-Resection in Crohn’s Disease Patients

/ Anja Poulsen
CrohnsECCO24 Play the Video 04:49
Joana Revés

No Association Between Bowel Damage and Disability in Patients with Recently Diagnosed Crohn’s Disease

/ Joana Revés
CrohnsECCO24 Play the Video 06:52
Back to top